Jacobson Alan M, Braffett Barbara H, Cleary Patricia A, Dunn Rodney L, Larkin Mary E, Wessells Hunter, Sarma Aruna V
Research Institute, Winthrop University Hospital, Mineola, NY
The Biostatistics Center, The George Washington University, Rockville, MD.
Diabetes Care. 2015 Oct;38(10):1904-12. doi: 10.2337/dc15-0286. Epub 2015 Jul 22.
Limited information exists about the influence of urologic complications on health-related quality of life (HRQOL) in patients with type 1 diabetes.
We studied 664 men and 580 women from the Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications Study: mean ages were 51.6 ± 6.6 and 50.6 ± 7.2 years and duration of diabetes was 29.5 ± 4.8 and 29.8 ± 5.1 years, respectively. We assessed associations of sexual dysfunction, lower urinary tract symptoms (LUTS), and, in women, urinary incontinence (UI) with general quality of life (SF-36), perceived value of health (EuroQol-5), diabetes-related quality of life (Diabetes Quality of Life Scale [DQOL]), and psychiatric symptoms (Symptom Checklist 90-R).
In both men and women, urologic complications adversely affected HRQOL and psychiatric symptoms, even after accounting for history of depression leading to treatment. Multivariable analyses accounting for the presence of diabetic retinopathy, neuropathy, and nephropathy also revealed substantial independent effects. In men, for example, the odds (95% CI) of a low DQOL score (≤25th percentile) were 3.01 (1.90-4.75) times greater with erectile dysfunction and 2.65 (1.68-4.18) times greater with LUTS and in women, 2.04 (1.25-3.35) times greater with sexual dysfunction and 2.71 (1.72-4.27) times greater with UI/LUTS combined compared with men and women without such complications. Similar effects were observed for the other measures.
Sexual dysfunction and urinary complications with type 1 diabetes are associated with decreased quality of life and perceived value of health and with higher levels of psychiatric symptoms, even after accounting for other diabetes complications and depression treatment.
关于泌尿系统并发症对1型糖尿病患者健康相关生活质量(HRQOL)的影响,现有信息有限。
我们对糖尿病控制与并发症试验/干预与并发症流行病学研究中的664名男性和580名女性进行了研究:平均年龄分别为51.6±6.6岁和50.6±7.2岁,糖尿病病程分别为29.5±4.8年和29.8±5.1年。我们评估了性功能障碍、下尿路症状(LUTS)以及女性尿失禁(UI)与总体生活质量(SF-36)、健康感知价值(欧洲五维度健康量表[EuroQol-5])、糖尿病相关生活质量(糖尿病生活质量量表[DQOL])和精神症状(症状自评量表90修订版[Symptom Checklist 90-R])之间的关联。
在男性和女性中,即使考虑了导致接受治疗的抑郁病史,泌尿系统并发症仍对HRQOL和精神症状产生不利影响。对糖尿病视网膜病变、神经病变和肾病的存在进行多变量分析后,也显示出显著的独立影响。例如,在男性中,勃起功能障碍患者DQOL评分低(≤第25百分位数)的比值(95%CI)比无此并发症的男性高3.01(1.90 - 4.75)倍,LUTS患者高2.65(1.68 - 4.18)倍;在女性中,性功能障碍患者高2.04(1.25 - 3.35)倍,UI/LUTS合并存在的患者比无此并发症的女性高2.71(1.72 - 4.27)倍。其他指标也观察到类似影响。
即使考虑了其他糖尿病并发症和抑郁治疗情况,1型糖尿病患者的性功能障碍和泌尿系统并发症仍与生活质量下降、健康感知价值降低以及精神症状水平升高有关。